-
Boceprevir (INN,
trade name Victrelis) is a
protease inhibitor used to
treat hepatitis caused by
hepatitis C
virus (HCV)
genotype 1. It
binds to the HCV...
- with interferon-α,
ribavirin and
protease inhibitors such as telaprevir,
boceprevir or the
nucleotide analog polymerase inhibitor sofosbuvir.
Biopsies of...
- inhibitors. This
residue had
previously been used in the
synthesis of
boceprevir. Tert-leucine (abbreviation: Tle) used in the P3
position of nirmatrelvir...
-
virus NS3/4A
protease inhibitors—class stem –previr: 26
Asunaprevir Boceprevir Grazoprevir Glecaprevir Paritaprevir Simeprevir Telaprevir 3-chymotrypsin-like...
- (INN)
blosozumab (INN)
Bluboro bluensomycin (INN) BMS 337039 BMS-232632
boceprevir (USAN, INN)
bofumustine (INN)
bolandiol (INN)
bolasterone (INN) bolazine...
- HIV Bictegravir:
INSTI Emtricitabine: NRTI
Tenofovir alafenamide: NRTI
Boceprevir Hepatitis C
genotype 1 Schering-Plough, then
Merck Group Protease inhibitor...
-
benzodiazepines anticoagulants antihistamines atazanavir birth-control
pills boceprevir Caution is
needed in
people using:
Medications such as
opioids or benzodiazepines...
- did not
respond to a
prior course of interferon-based therapy. Merck's
boceprevir, also a new
antihepatitis C drug, was
given a
positive recommendation...
-
expected to
interact with
daridorexant include the
strong CYP3A4
inhibitors boceprevir, clarithromycin, conivaptan, indinavir, itraconazole, ketoconazole, lopinavir...
-
three classes: NS3 and NS4A
protease inhibitors,
including telaprevir,
boceprevir, simeprevir, and
others NS5A inhibitors,
including ledipasvir, daclatasvir...
